J&J’s $223.8 million talc cancer verdict overturned by court.
By Brendan Pierson
Oct 3 (Reuters) – A New Jersey appeals court on Tuesday threw out a $223.8 million verdict against Johnson & Johnson (JNJ.N) that a jury had awarded to four plaintiffs who claimed they developed cancer from being exposed to asbestos in the company’s talc powder products.
The Superior Court of New Jersey, Appellate Division found that a lower court judge should not have allowed some of the scientific expert testimony the plaintiffs presented to jurors at trial.
J&J Worldwide Vice President of Litigation Erik Haas said in a statement that the decision “resoundingly rejects … the ‘junk science’ advanced by purported ‘experts’ paid by the mass tort asbestos bar.” The company again said that its talc products are safe and do not contain asbestos.
A lawyer for the plaintiffs did not immediately respond to a request for comment.
The jury in the case had ordered the company to pay $37.2 million in compensatory damages and $750 million in punitive damages, though that amount was automatically reduced to $186.5 million under state law.
In reversing the verdict and ordering a new trial, a three-judge panel of the appeals court found that the trial court failed to fulfill its “gatekeeping role” of assessing whether the plaintiffs’ experts based their testimony on sound science.
In their opinion, the judges found that three experts had not explained the facts or methods they used to support their opinions that the plaintiffs got cancer from being exposed to asbestos in talc products.
J&J is separately suing one of those experts, Jacqueline Moline, over a study she co-authored in 2019. That study was not at issue in Tuesday’s decision.
Moline, who has testified for plaintiffs in more than 200 talc cancer cases, has argued that the lawsuit is an effort to “intimidate” scientific experts and prevent them from testifying against the company.
J&J faces more than 38,000 lawsuits alleging that its talc products, including Johnson’s baby powder, can contain asbestos, and caused cancers including ovarian cancer and mesothelioma, a type of cancer linked to asbestos exposure.
The claims have a mixed record of success, with major plaintiff wins including a $2.1 billion judgment awarded to 22 women with ovarian cancer. That verdict was upheld by an appeals court, and the U.S. Supreme Court declined to review it.
J&J has recently won reversals of some cases that went against it, including of a $117 million verdict in the same New Jersey appeals court and a $120 million verdict in New York.
The company’s latest win comes after it failed for a second time in July to move tens of thousands of claims over talc into bankruptcy court, where it hoped to resolve them through a proposed $8.9 billion settlement. It is appealing that ruling.
Trials had mostly been on hold while J&J petitioned the bankruptcy court, but will now be able to resume. One trial that was allowed while the bankruptcy petition was pending ended with an $18.8 million verdict for a terminally ill California man.
J&J has said the cost of its talc-related verdicts, settlements and legal fees have reached about $4.5 billion.
The company stopped selling talc-based baby powder in favor of cornstarch-based products, citing an increase in lawsuits and “misinformation” about the talc product’s safety.
Reporting By Brendan Pierson in New York; editing by Alexia Garamfalvi and Bill Berkrot
The Biden White House is halting international travel for senior officials promoting carbon-intensive fuels.
Hunter Biden, son of President Biden, pleads not guilty in Federal Court on gun charges.
California Governor Gavin Newsom appoints the first openly gay black woman to the U.S. Senate following the passing of Senator Dianne Feinstein.
Interview with Rep. Nicole Malliotakis
Meta plans layoffs in its Reality Labs division focused on custom silicon.
The fraud trial of Sam Bankman-Fried, founder of a bankrupt cryptocurrency exchange, begins with jury selection.
The global cryptocurrency market continues to recover from the collapse of FTX and other major players.
A California judge rules that Tesla car owners must pursue autopilot claims through arbitration instead of court.
rnrn
What does the court’s decision mean for J&J and the ongoing litigation regarding their talc products
Title: New Jersey Appeals Court Overturns $223.8 Million Verdict Against Johnson & Johnson in Talc Powder Cancer Case
Introduction:
In a recent development, a New Jersey appeals court has thrown out a $223.8 million verdict against Johnson & Johnson (J&J), which was awarded by a jury to four plaintiffs claiming cancer from asbestos exposure in the company’s talc powder products. The court found that the lower court judge made errors in allowing certain scientific expert testimonies presented by the plaintiffs during the trial. This decision has been perceived as a resounding rejection of what J&J refers to as “junk science” put forward by paid “experts.”
Background:
The Superior Court of New Jersey’s Appellate Division ruled that the trial court failed to fulfill its role of assessing the plaintiffs’ experts’ scientific basis for their testimonies. The appeals court highlighted that three experts had not adequately explained the facts or methods used to support their opinions regarding the cancer development from asbestos exposure in talc products.
J&J’s Response and Future Implications:
J&J Worldwide Vice President of Litigation Erik Haas welcomed the decision, emphasizing its rejection of the alleged “junk science” put forward by experts associated with the mass tort asbestos bar. The company reiterated its stance that its talc products are safe and asbestos-free.
The Impact on Litigation:
J&J faces more than 38,000 lawsuits accusing their talc products, including Johnson’s baby powder, of containing asbestos and causing different types of cancer, including ovarian cancer and mesothelioma. The outcome of these lawsuits has varied, with some major victories for plaintiffs, including a $2.1 billion judgment in favor of 22 women with ovarian cancer, which was upheld by an appeals court.
J&J’s Recent Legal Wins:
Despite some significant legal setbacks, J&J has recently experienced positive outcomes in its legal battles. The company successfully appealed a $117 million verdict in the same New Jersey appeals court, as well as a $120 million verdict in New York. These rulings have provided J&J with some respite amidst ongoing litigations and negotiations.
Ongoing Bankruptcy Proceedings:
In an attempt to resolve thousands of claims related to talc products, J&J had previously sought to move them into bankruptcy court. However, the company failed to secure approval for this move and the subsequent proposed $8.9 billion settlement. J&J is currently appealing this ruling, which has resulted in trials being on hold. With the recent court decision overturning the $223.8 million verdict, trials can now resume.
Conclusion:
The New Jersey appeals court’s decision to overturn the $223.8 million verdict against J&J provides the company with a significant legal relief. It emphasizes the significance of thorough scientific evidence and proper assessment in determining liability in such cases. The outcome also highlights the complexity and diversity of opinions surrounding the alleged connection between talc products and cancer, as well as the ongoing legal battle faced by J&J.
" Conservative News Daily does not always share or support the views and opinions expressed here; they are just those of the writer."
*As an Amazon Associate I earn from qualifying purchases
Now loading...